NLR family pyrin domain containing 3 (NLRP3) inflammasome complex (NLRP3 inflammasome)

The NLR family pyrin domain containing 3 (NLRP3) inflammasome complex is a multi-protein intracellular signaling platform that plays a pivotal role in the innate immune system's response to infection and cellular stress [PMID: 31034466]. It consists of the NLRP3 sensor protein, the adapter protein ASC (apoptosis-associated speck-like protein containing a CARD), and the effector enzyme pro-caspase-1 [UniProt: Q96P20]. Upon activation by a diverse array of stimuli—including extracellular ATP, crystalline particles like uric acid, and pore-forming toxins—the complex assembles to trigger the maturation of pro-inflammatory cytokines interleukin-1 beta (IL-1β) and interleukin-18 (IL-18) [StatPearls: Inflammasome]. This process also leads to pyroptosis, a form of programmed inflammatory cell death that further amplifies the immune response [PMID: 27951526]. Chronic or excessive activation of this pathway is a major driver of various inflammatory pathologies, ranging from rare autoinflammatory syndromes like Cryopyrin-Associated Periodic Syndromes (CAPS) to common metabolic and neurodegenerative diseases [PMID: 33035211]. Therapeutic strategies targeting the NLRP3 inflammasome focus on small-molecule inhibitors that prevent its assembly or activation, offering a promising approach to treating systemic inflammation [PMID: 31034466]. Several inhibitors, such as Dapansutrile, are currently in clinical trials for conditions like gout and heart failure [ClinicalTrials.gov: NCT03034486]. By specifically targeting the NLRP3 sensor, these drugs aim to provide potent anti-inflammatory effects while minimizing the broad immunosuppression associated with upstream cytokine blockers.

Other names

NALP3 inflammasomeCryopyrin inflammasomeCIAS1PYPAF1Caspase recruitment domain-containing protein 7

Inhibition of the NLRP3 ATPase activity, prevention of NLRP3 oligomerization, or blocking the recruitment of the ASC adapter protein, thereby preventing the activation of caspase-1 and the subsequent release of IL-1β and IL-18 [PMID: 31034466].